GLP-1 agonist drugs like Ozempic work by stimulating the GLP-1 receptor in the body, which helps increase insulin secretion, reduce glucagon release, slow down stomach emptying, and promote a feeling of fullness
Because they havent undergone the FDAs strict testing for safety and efficacy, theres no way to know if they work or what health risks they might pose
The Murine Glucagon-Like Peptide-1 Receptor Is Essential for Control of Bone Resorption
By reducing inflammation and promoting tissue repair, it helps you stay active and recover faster, which indirectly supports muscle development over time
They slow gastric emptying , reduce appetite signals in the brain, improve insulin sensitivity, and alter food reward pathways
Research highlights its potential in weight management, appetite control, glucose homeostasis, and energy balance, providing insights into obesity, type 2 diabetes, and related metabolic disorders